ImmuPharma PLC (UK) Analysis

ImmuPharma Stock Analysis Notes

About 48.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.81. Some equities with similar Price to Book (P/B) outperform the market in the long run. ImmuPharma PLC recorded a loss per share of 0.01. The entity last dividend was issued on the 14th of December 2021. The firm had 1:1 split on the 17th of August 2022. To learn more about ImmuPharma PLC call XIV FCCA at 44 20 7206 2650 or check out https://www.immupharma.co.uk.

ImmuPharma PLC Investment Alerts

ImmuPharma Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.88 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ImmuPharma PLC's market, we take the total number of its shares issued and multiply it by ImmuPharma PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

ImmuPharma PLC has return on total asset (ROA) of (0.43) % which means that it has lost $0.43 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.112) %, meaning that it generated substantial loss on money invested by shareholders. ImmuPharma PLC's management efficiency ratios could be used to measure how well ImmuPharma PLC manages its routine affairs as well as how well it operates its assets and liabilities. At present, ImmuPharma PLC's Intangible Assets are projected to decrease significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 5.2 M, whereas Non Current Assets Total are forecasted to decline to about 1.4 M.

Technical Drivers

As of the 11th of December 2024, ImmuPharma PLC retains the Standard Deviation of 3.98, market risk adjusted performance of (6.81), and Risk Adjusted Performance of (0.07). ImmuPharma PLC technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out ImmuPharma PLC treynor ratio, as well as the relationship between the value at risk and skewness to decide if ImmuPharma PLC is priced fairly, providing market reflects its last-minute price of 1.13 per share.

ImmuPharma PLC Price Movement Analysis

ImmuPharma PLC Outstanding Bonds

ImmuPharma PLC Predictive Daily Indicators

ImmuPharma PLC Forecast Models

ImmuPharma PLC's time-series forecasting models are one of many ImmuPharma PLC's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ImmuPharma PLC's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how ImmuPharma PLC prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ImmuPharma shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ImmuPharma PLC. By using and applying ImmuPharma Stock analysis, traders can create a robust methodology for identifying ImmuPharma entry and exit points for their positions.

When running ImmuPharma PLC's price analysis, check to measure ImmuPharma PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmuPharma PLC is operating at the current time. Most of ImmuPharma PLC's value examination focuses on studying past and present price action to predict the probability of ImmuPharma PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmuPharma PLC's price. Additionally, you may evaluate how the addition of ImmuPharma PLC to your portfolios can decrease your overall portfolio volatility.